The true prognosis of resected distal cholangiocarcinoma

Journal of Surgical Oncology

Volumn 113, Issue 5, 2016, Pages 575-580

  Courtin Tanguy, Laetitia ^a,b,c   Rayar, Michel ^a,b,c   Bergeat, Damien ^a,b,c   Merdrignac, Aude ^a,b,c   Harnoy, Yann ^a,b,c   Boudjema, Karim ^a,b,c   Meunier, Bernard ^a,b   Sulpice, Laurent ^a,b,c  

^a RENNES UNIVERSITY HOSPITAL   (France)

^b UNIVERSITÉ DE RENNES 1   (France)

^c INSERM   (France)

Author keywords

distal cholangiocarcinoma; prognosis; recurrence

Indexed keywords

AGED; ARTICLE; BILE DUCT CARCINOMA; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER RISK; CANCER SURVIVAL; CARCINOMA; DISEASE FREE SURVIVAL; DISTAL CHOLANGIOCARCINOMA; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PANCREAS ADENOCARCINOMA; PERIAMPULLARY CARCINOMA; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; ADULT; BILE DUCT NEOPLASMS; CARCINOMA, PANCREATIC DUCTAL; CHOLANGIOCARCINOMA; MIDDLE AGED; MORTALITY; PANCREATIC NEOPLASMS; PANCREATICODUODENECTOMY; PATHOLOGY; PROPENSITY SCORE; RETROSPECTIVE STUDY; SURVIVAL RATE; TREATMENT OUTCOME; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; BILE DUCT NEOPLASMS; CARCINOMA, PANCREATIC DUCTAL; CHOLANGIOCARCINOMA; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; MALE; MIDDLE AGED; PANCREATIC NEOPLASMS; PANCREATICODUODENECTOMY; PROPENSITY SCORE; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84955056898     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.24165     Document Type: Article

References (30)

1. Razumilava N, Gores GJ,: Classification, diagnosis, and management of cholangiocarcinoma. Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc 2013; 11: 13-21 e1; quiz e3-4.
2. Tol JA, Brosens LA, van Dieren S, et al.,: Impact of lymph node ratio on survival in patients with pancreatic and periampullary cancer. Br J Surg 2015; 102: 237-245.
3. Nakase A, Matsumoto Y, Uchida K, et al.,: Surgical treatment of cancer of the pancreas and the periampullary region: Cumulative results in 57 institutions in Japan. Ann Surg 1977; 185: 52-57.
4. Blechacz B, Komuta M, Roskams T, et al.,: Clinical diagnosis and staging of cholangiocarcinoma. Nat Rev Gastroenterol Hepatol 2011; 8: 512-522.
5. Turaga KK, Tsai S, Wiebe LA, et al.,: Novel multimodality treatment sequencing for extrahepatic (mid and distal) cholangiocarcinoma. Ann Surg Oncol 2013; 1230-1239.
6. Penz M, Kornek GV, Raderer M, et al.,: Phase II trial of two-weekly gemcitabine in patients with advanced biliary tract cancer. Ann Oncol Off J Eur Soc Med Oncol ESMO 2001; 12: 183-186.
7. Oshiro Y, Takahashi K, Sasaki R, et al.,: Adjuvant surgery for advanced extrahepatic cholangiocarcinoma. World J Gastroenterol WJG 2013; 19: 6934-6938.
8. Van der Gaag NA, Kloek JJ, de Bakker JK, et al.,: Survival analysis and prognostic nomogram for patients undergoing resection of extrahepatic cholangiocarcinoma. Ann Oncol Off J Eur Soc Med Oncol ESMO 2012; 23: 2642-2649.
9. Qiao Q-L, Zhang T-P, Guo J-C, et al.,: Prognostic factors after pancreatoduodenectomy for distal bile duct cancer. Am Surg 2011; 77: 1445-1448.
10. Murakami Y, Uemura K, Sudo T, et al.,: Prognostic factors after surgical resection for intrahepatic, hilar, and distal cholangiocarcinoma. Ann Surg Oncol 2011; 18: 651-658.
11. Park S, Kim JH, Won HJ, et al.,: Radiofrequency ablation of hepatic metastases after curative resection of extrahepatic cholangiocarcinoma. AJR Am J Roentgenol 2011; 197: W1129-W1134.
12. Dickson PV, Behrman SW,: Distal cholangiocarcinoma. Surg Clin North Am 2014; 94: 325-342.
13. Hatzaras I, George N, Muscarella P, et al.,: Predictors of survival in periampullary cancers following pancreaticoduodenectomy. Ann Surg Oncol 2010; 17: 991-997.
14. Owens WD, Felts JA, Spitznagel EL,: ASA physical status classifications: A study of consistency of ratings. Anesthesiology 1978; 49: 239-243.
15. Bassi C, Dervenis C, Butturini G, et al.,: Postoperative pancreatic fistula: An international study group (ISGPF) definition. Surgery 2005; 138: 8-13.
16. Wente MN, Bassi C, Dervenis C, et al.,: Delayed gastric emptying (DGE) after pancreatic surgery: A suggested definition by the International Study Group of Pancreatic Surgery (ISGPS). Surgery. 2007; 142: 761-768.
17. Dindo D, Demartines N, Clavien P-A,: Classification of surgical complications: A new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 2004; 240: 205-213.
18. Kayahara M, Nagakawa T, Ohta T, et al.,: Role of nodal involvement and the periductal soft-tissue margin in middle and distal bile duct cancer. Ann Surg 1999; 229: 76-83.
19. Woo SM, Ryu JK, Lee SH, et al.,: Recurrence and prognostic factors of ampullary carcinoma after radical resection: Comparison with distal extrahepatic cholangiocarcinoma. Ann Surg Oncol 2007; 14: 3195-3201.
20. Kiriyama M, Ebata T, Aoba T, et al.,: Prognostic impact of lymph node metastasis in distal cholangiocarcinoma. Br J Surg 2015; 102: 399-406.
21. Ito K, Ito H, Allen PJ, et al.,: Adequate lymph node assessment for extrahepatic bile duct adenocarcinoma. Ann Surg 2010; 251: 675-681.
22. Murakami Y, Uemura K, Hayashidani Y, et al.,: Pancreatoduodenectomy for distal cholangiocarcinoma: Prognostic impact of lymph node metastasis. World J Surg 2007; 31: 337-42; discussion 343-4.
23. Noji T, Miyamoto M, Kubota KC, et al.,: Evaluation of extra capsular lymph node involvement in patients with extra-hepatic bile duct cancer. World J Surg Oncol 2012; 10: 106.
24. Hernandez J, Cowgill SM, Al-Saadi S, et al.,: An aggressive approach to extrahepatic cholangiocarcinomas is warranted: margin status does not impact survival after resection. Ann Surg Oncol 2008; 15: 807-814.
25. Horgan AM, Amir E, Walter T, et al.,: Adjuvant therapy in the treatment of biliary tract cancer: A systematic review and meta-analysis. J Clin Oncol Off J Am Soc Clin Oncol 2012; 30: 1934-1940.
26. Takao S, Shinchi H, Uchikura K, et al.,: Liver metastases after curative resection in patients with distal bile duct cancer. Br J Surg 1999; 86: 327-331.
27. Todoroki T, Kawamoto T, Koike N, et al.,: Treatment strategy for patients with middle and lower third bile duct cancer. Br J Surg 2001; 88: 364-370.
28. Choi SB, Park SW, Kim KS, et al.,: The survival outcome and prognostic factors for middle and distal bile duct cancer following surgical resection. J Surg Oncol 2009; 99: 335-342.
29. Ercolani G, Vetrone G, Grazi GL, et al.,: Intrahepatic cholangiocarcinoma: Primary liver resection and aggressive multimodal treatment of recurrence significantly prolong survival. Ann Surg 2010; 252: 107-114.
30. Sulpice L, Rayar M, Boucher E, et al.,: Treatment of recurrent intrahepatic cholangiocarcinoma. Br J Surg. 2012; 99: 1711-1717.